Invictus MD (TSXV:IMH) announced today that it has engaged Canaccord Genuity Corp. and Eventus Capital Corp., as co-lead underwriters and joint-bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal private placement basis, subject to adjustment
Nano Dimension (TASE:NNDM,NASDAQ:NNDM), announced today that its wholly owned subsidiary, Nano Dimension Technologies Ltd., has supplied its flagship DragonFly 2020 3D Printer to a PCB design bureau, located in Israel. This design bureau helps a broad range of companies design and manufacture PCBs, and will examine Nano Dimension’s cutting-edge technology.
Invictus MD (TSXV:IMH) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), will provide their unique products in Canopy Growth Corporation’s (TSX:WEED) (“Canopy Growth”) curated CraftGrow line on Tweed Main Street’s online store, that brings high
CytRx Corporation leads the list of last week’s life science gainers on the NASDAQ, followed by Rockwell Medical, ImmunoGen, NewLink Genetics and TearLab.
Invictus MD (TSXV:IMH) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.787 million in revenue for the 9 months ending March 31, 2017, with a gross margin of $907,864, representing a 50.8% gross margin compared to the same
By Pia Rivera
BioSig Technologies, Inc. (OTCQB: BSGM) announced its Chairman Kenneth L. Londoner will be presenting at the Monaco Growth Forums Spring Edition April 24th at the Mondrian Hotel in London, England, and April 25th – 26th at The Fairmont Hotel in Monte Carlo, Monaco.
Moleculin Biotech announced it appointed Theradex Systems as its contract research organization for the Phase I/II clinical trials for Annamycin.
Acreage Pharms Ltd., which Invictus MD (CNX:IMH). has the option to now acquire 100 per cent of and expects to exercise in short order, has begun its new cultivation cycle, having received its licence to cultivate under the access to cannabis for medical purposes regulations (ACMPR); Acreage is firmly committed
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced the Company closed a private placement with proceeds of $4,349,953.50. Laidlaw & Co (UK) Ltd. in New
Algold Resources Ltd. (TSXV:ALG) today released preliminary assay results from its phase 3 20,000-metre drilling campaign carried out on its Tijirit property in Mauritania. Results continue to demonstrate the high-grade nature of the Eleonore zone, with the mineralization now extending to a vertical depth of up to 150 metres.
Nano Dimension (TASE:NNDM,NASDAQ:NNDM) announced today that its wholly owned subsidiary, Nano Dimension Technologies Ltd., is working together with Zuken Inc. to advance the 3D printing user experience and prototype turnaround times. Nano Dimension will take advantage of the support for implementing electronic technologies provided by Zuken’s market-leading, native 3D, system-level
Nano Dimension (TASE:NNDM,NASDAQ:NNDM), announced today that its wholly owned subsidiary, Nano Dimension Technologies Ltd., has filed a patent application with the U.S. Patent and Trademark Office for the development of three-dimensional (3D) inkjet printing of bio-artificial multi-layered complex structures composed of cells, extracellular matrices, supportive components and stable and fugitive
Invictus MD (CNX:IMH), Canada’s cannabis company, is pleased to announce that its common shares will be delisted from the Canadian Securities Exchange after the close of trading on March 30, 2017 and will be listed on the TSX Venture Exchange (“TSXV”) commencing at the open of trading on March 31,
Graphene 3D Lab Inc. announces that it has concluded the Confidential Research and Development Agreement (the “Agreement”) with its partner, a Fortune 500 Manufacturer (the “Partner”). The Agreement and the general terms of the arrangement were initially announced on December 1, 2015.
By Pia Rivera
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced it will host five Lafayette College students as part of an immersive internship program.
Under the leadership of